Currently predicting for Thu, 4 Jun 2026

ESPR Prediction Chart

ESPR Predictions History

Latest community submissions for ESPR.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
May 24, 2021 $21.33 +5.23% $20.27 X 94.77% 0
May 24, 2021 Bullish $20.27 X 0
JS JS Pro
May 13, 2021 $23.96 +6.96% $22.40 X 93.04% 0
May 13, 2021 $21.97 -1.92% $22.40 X 98.08% 0
JS JS Pro
Mar 29, 2021 $26.81 -3.28% $27.72 X 96.72% 0
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 29, 2021 $46.00 +65.95% $27.72 X 34.05% 1
Justin Peck Justin Peck @JustinPeck.218243
Mar 29, 2021 $28.06 +1.23% $27.72 X 98.77% 2
May 8, 2020 Bullish $46.57 X 1
May 7, 2019 $42.63 -11.91% $48.39 X 88.09% 0
May 1, 2019 $44.30 +5.48% $42.00 X 94.52% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ESPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE